{"id":"W3003699744","doi":"10.1158/1078-0432.ccr-19-2576","title":"Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); Alberta Cancer Foundation; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Cabozantinib; Endometrial cancer; Medicine; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003494212,0.0009652338,0.001093165,0.0003658721,0.0005840064,0.0006998049,0.0006419545,0.001167441,0.003382758],"category_scores_gemma":[0.001632055,0.0005053877,0.0008729721,0.0004657471,0.0006684421,0.0003943244,0.0003560912,0.00164463,0.0004648868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001038519,"about_ca_system_score_gemma":0.002635177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004249144,"about_ca_topic_score_gemma":0.01143192,"domain_scores_codex":[0.9993128,0.0004716488,0.00002693181,0.00008134013,0.00005560177,0.00005164927],"domain_scores_gemma":[0.9987122,0.0002259803,0.0002661627,0.00008779542,0.0001165054,0.0005912522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8662897,0.0178669,0.01414297,0.0009089106,0.001859999,0.0002136129,0.0003006586,0.001201251,0.01277493,0.0002391856,0.00897184,0.0752301],"study_design_scores_gemma":[0.8833625,0.09477314,0.01679954,0.00004957728,0.000540261,0.000121999,0.00003652571,0.000606285,0.000539021,0.00007164733,0.003082876,0.00001665238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814898,0.006433888,0.0004739559,0.001423239,0.0001866931,0.004521521,0.00177295,0.00007875368,0.0036191],"genre_scores_gemma":[0.9799688,0.004164001,0.001908208,0.002251378,0.0004592134,0.004459852,0.003042572,0.0000221179,0.003723829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004249144,"threshold_uncertainty_score":0.01847941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3313439728088638,"score_gpt":0.548327161618752,"score_spread":0.2169831888098882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}